AS

ASBP

XNAS

Aspire Biopharma Holdings, Inc.

Mkt Cap $5MPHARMACEUTICAL PREPARATIONS

FUNDAMENTALS

P/S

170.12

EV/EBITDA

-0.07

P/B

-0.17

EPS (TTM)

$-4.87

ROE

383.9%

ROA

-1865.7%

MKT CAP

$1.1M

TECHNICAL ANALYSIS

Leaning Bullish

RSI-14

31.1

Oversold

MACD

-0.237

Bearish

SMA-50

$0.90

$0.90

SMA-200

$7.92

$7.92

BOLL %B

0.29

Within bands

ATR-14

$0.12

RVOL

0.26x

Low activity

MOMENTUM

+3.5%

10d -21.3% / 30d -67.7%

Analysis History

AI PREDICTION

No prediction yet

Tap Analyze to generate

REVENUE & GROWTH

$4,261

Revenue

+119.5%

QoQ

0.0%

YoY

Gross Margin

-23.5%Contracting

SHORT & FLOAT

Free Float

89.7%